The raw statistics are quite promising; a study that found occasionally donating blood (every three years) is associated with a 50% drop in cardiovascular disease in men. This study finds a 40% reduction in cardiovascular risk, after adjusting for other differences between donor and non-donor groups. a study that found occasionally donating blood (every three years) is associated with a 50% drop in cardiovascular disease in men.
Elizabeth Parrish is the CEO of BioViva, a biotech company in the Seattle area that is focused on developing gene therapies that may one day mitigate the diseases of aging.
I have just returned from the first Monod Conference on the Comparative Biology of Aging.
While emerging anti-aging technologies are still emerging, the best-tested treatments we have for the present all rely on the insulin metabolism.
this video Dr. Fahy discusses the latest advances in the field of Cryonics, including vitrification and organ banking.
At first, only trivial amounts of beta amyloid begin to accumulate in small aggregates, but then they grow larger, gathering into huge amyloid plaques.
There has been emerging a tradition by longevity researchers and activists around the world to organize events dedicated to promotion of longevity research on or around October 1 – the UN International Day of Older Persons.
Tests with human subjects require decades, and are impossible to control, so the gold standard for testing claims for treatments that delay aging is the controlled trial with rodents, usually mice.
Part of BBC’s ‘Intelligent Machines Week’ and includes an excellent interview with Humanity+ board member Dr. Ben Goertzel, and more.
In the 1980s, Growth Hormone was explored by athletes to build muscles and by aging men to…build muscles. GH made them feel younger, revived energy and sex drive and even cognitive performance. Then the other shoe dropped: Animals without the GH receptor lived longer, while animals with extra copies of the GH gene die early.